NGL Fine-Chem Limited receives CEP from EDQM for TRICLABENDAZOLE

NGL Fine-Chem Limited has received Certificate of suitability No. CEP 2022-025 - Rev 00, from European Directorate for the Quality of Medicines & Healthcare (EDQM) for its product TRICLABENDAZOLE. This certificates facilitates registration and use of Triclabendazole manufactured by NGL Fine-Chem Limited by the European customers for their finished product.

Shares of NGL FINE-CHEM LTD. was last trading in BSE at Rs. 2380.65 as compared to the previous close of Rs. 2419.55. The total number of shares traded during the day was 359 in over 77 trades.

The stock hit an intraday high of Rs. 2468.15 and intraday low of 2380.65. The net turnover during the day was Rs. 865798.00.

Source : Equity Bulls

Keywords

NGLFINECHEM INE887E01022 CEP EDQM TRICLABENDAZOLE